S&P 500
(-0.17%) 5 460.05 points
Dow Jones
(-0.13%) 39 061 points
Nasdaq
(0.08%) 17 733 points
Oil
(-0.14%) $80.72
Gas
(-3.70%) $2.65
Gold
(-0.70%) $2 314.40
Silver
(0.16%) $28.92
Platinum
(2.00%) $1 006.10
USD/EUR
(0.32%) $0.936
USD/NOK
(0.76%) $10.68
USD/GBP
(0.50%) $0.792
USD/RUB
(0.01%) $87.50

के लिए वास्तविक समय के अद्यतन Lexeo Therapeutics, Inc. [LXEO]

एक्सचेंज: NASDAQ क्षेत्र: Healthcare उद्योग: Biotechnology
अंतिम अद्यतन26 Jun 2024 @ 20:56

-4.33% $ 16.14

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:56):
Our systems believe the stock currently is undervalued by 0.07% compare to its pairs and should correct upwards.

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich\'s ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations...

Stats
आज की मात्रा 27 087
औसत मात्रा 145 361
बाजार मूल्य 531.74M
EPS $-0.770 ( Q1 | 2024-03-31 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0800 (0.50%)
AADI -2.65%
ABCL 1.47%
ABCM 0.04%
ABEO -2.84%
ABIO -1.68%
ABOS 1.64%
ABSI 3.07%
ABUS -2.29%
ABVX -3.53%
ACAD -0.71%
ACER -17.95%
ACET -4.12%
ACGN 1.29%
ACHL -3.00%
ACHV -1.72%
ACIU -1.00%
ACLX -0.04%
ACRV -4.79%
ACST -1.63%
ACXP 0.65%
ADAG 4.64%
ADAP -2.91%
ADGI 0.87%
ADIL 0.54%
ADMA -2.68%
ADPT -0.30%
ADTX -3.47%
ADVM -3.91%
ADXN -1.60%
AEON -3.74%
AEZS -3.51%
AFMD -1.40%
AGEN -1.82%
AGIO -2.04%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -3.46%
AKRO -2.89%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -2.29%
ALGS -2.41%
ALKS -0.19%
ALLK -9.28%
ALLO -6.24%
ALLR -3.32%
ALNA 3.16%
ALNY 1.82%
ALPN 0.02%
ALPX 0.00%
ALRN -0.33%
ALT -9.51%
ALVR -0.56%
ALXN 0.00%
ALXO -10.96%
ALZN 4.78%
AMRN -0.31%
AMTI -3.13%
ANAB 0.46%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.66%
ANPC -3.15%
APGE -0.91%
APGN 8.48%
APGNW 30.65%
APLM 1.56%
APLS 0.00%
APLT -5.41%
APM -1.47%
APOP 0.38%
APRE 2.29%
APTO 3.27%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -3.84%
ARDS -14.23%
ARDX -0.75%
ARGX -0.81%
ARNA 0.00%
ARPO -0.90%
ARQT -0.52%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.63%
ARWR -1.71%
ASLN -4.71%
ASMB -7.14%
ASND -0.94%
ATAI -1.11%
ATHA 5.94%
ATHE 1.12%
ATHX -33.50%
ATNF 0.99%
ATOS 2.89%
ATRA -3.22%
ATXI 1.93%
ATXS -0.89%
AUPH -1.17%
AURA 1.17%
AUTL -1.72%
AVBP -2.86%
AVEO 0.00%
AVIR -0.15%
AVRO -1.41%
AVTE -4.84%
AVTX -1.25%
AVXL -2.72%
AXLA 0.00%
AXSM -1.99%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.90%
BCAB 2.28%
BCDA -2.07%
BCDAW -41.77%
BCEL 0.00%
BCLI 7.14%
BCRX 1.23%
BCTX 7.65%
BCTXW -17.37%
BCYC 1.10%
BDRX -3.52%
BDTX -0.85%
BEAM 0.45%
BFRA -2.91%
BGNE -2.72%
BIOR -3.40%
BIVI 1.26%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.85%
BLTE -0.62%
BLU 0.03%
BLUE -0.52%
BMEA -9.98%
BMRN 0.36%
BNOX -2.22%
BNTC -2.11%
BNTX -1.55%
BOLD -7.90%
BOLT 1.31%
BPMC -1.27%
BPTH 1.86%
BPTS -13.47%
BRNS -0.74%
BRTX -2.36%
BTAI 23.31%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.39%
CABA 0.48%
CADL -1.05%
CALA 0.00%
CALC -1.77%
CALT -0.59%
CAPR -2.80%
CARA 0.21%
CARM 12.13%
CASI -1.67%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -6.89%
CCCC -5.31%
CCXI 0.00%
CDAK 0.00%
CDIO -2.02%
CDIOW 24.00%
CDMO -2.82%
CDMOP 0.04%
CDT -10.57%
CDTTW -39.60%
CDTX -1.92%
CDXC 0.00%
CDXS 5.52%
CELC -4.25%
CELU -1.50%
CELUW 11.80%
CERC -1.68%
CERE -0.99%
CERO -3.40%
CEROW -10.18%
CFRX -27.95%
CGEM -2.50%
CGEN -3.31%
CGON -0.48%
CGTX -5.11%
CHMA -6.00%
CHRS -0.63%
CINC 0.00%
CING 2.56%
CINGW 34.95%
CKPT -2.87%
CLBS -16.75%
CLDX -2.26%
CLGN 0.34%
CLLS -4.15%
CLNN 2.42%
CLNNW 0.00%
CLRB 7.04%
CLSD 1.60%
CLSN -0.68%
CLVS 0.00%
CMMB -0.01%
CMND 3.63%
CMPI 0.00%
CMPX -8.03%
CMRA 0.00%
CMRAW 33.33%
CMRX -2.71%
CNCE 0.00%
CNSP -39.44%
CNST 0.00%
CNTA -0.67%
CNTB -2.25%
CNTX -6.85%
COCP -2.02%
COEPW 32.45%
COGT -2.83%
CORT 2.20%
COYA -1.46%
CPRX -0.99%
CRBP -1.88%
CRBU -5.10%
CRDF -1.77%
CRGX 1.28%
CRIS -0.38%
CRNX -5.86%
CRSP 0.97%
CRTX 2.63%
CRVO -2.50%
CRVS 1.12%
CSBR -1.59%
CTCX -1.63%
CTIC 0.06%
CTMX -2.49%
CTNM -0.65%
CTXR 1.46%
CUE 3.61%
CVAC -2.26%
CVKD -5.23%
CWBR 2.80%
CYAD -12.96%
CYCC 9.75%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -2.08%
CYTO -2.73%
DARE 6.41%
DAWN 0.75%
DBTX -0.81%
DBVT 4.44%
DFFN 10.28%
DICE 0.06%
DMAC 30.67%
DNLI -1.70%
DNTH -6.31%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 0.95%
DSGN -1.21%
DTIL 1.36%
DYAI 9.68%
EARS -1.77%
EDIT -2.41%
EDSA -1.00%
EFTR 8.18%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.98%
ELEV -4.98%
ELOX 7.69%
ELTX -0.88%
ELVN -3.87%
ELYM 1.05%
ENGN 1.67%
ENGNW 0.12%
ENLV 2.54%
ENOB 1.79%
ENSC 4.13%
ENTA -0.49%
ENTO -4.42%
ENTX 0.69%
ENVB 1.10%
EPIX -0.10%
EPRX -2.97%
EPZM 0.00%
EQ 0.86%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.20%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -1.02%
ETON 1.68%
ETTX 0.00%
EVAX -2.14%
EVGN 3.88%
EVLO 0.00%
EWTX 0.03%
EXAI -0.76%
EXEL -0.36%
EYEG -0.69%
EYEN 1.48%
EYPT -0.12%
FATE -7.80%
FBIO 0.59%
FBIOP 0.92%
FBLG -14.34%
FBRX -0.04%
FDMT -4.64%
FENC -0.97%
FGEN -5.13%
FHTX 1.43%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.68%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.31%
FULC -3.18%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -5.89%
GANX -1.49%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -4.31%
GHRS -1.59%
GLMD -2.32%
GLPG -2.26%
GLSI 2.80%
GLTO -0.57%
GLUE -1.58%
GLYC -10.03%
GMAB -0.43%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -0.52%
GNLX 1.33%
GNPX 0.00%
GNTA 3.94%
GOSS -8.92%
GOVX 5.93%
GOVXW -49.04%
GPCR -6.50%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.33%
GRTX 0.00%
GTHX 0.68%
GUTS -5.31%
GXGXW 41.67%
GYRE -7.16%
HALO -1.05%
HARP 0.09%
HCWB -3.75%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -0.77%
HOOK 0.80%
HOTH -2.70%
HOWL -2.14%
HRMY 0.85%
HRTX 2.30%
HSTO 0.00%
HUMA 1.32%
HUMAW -0.01%
IBRX -4.03%
ICCC 0.22%
ICPT 0.21%
ICU 16.82%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.95%
IFRX -1.85%
IGMS -0.15%
IKNA 0.60%
IKT 1.42%
IMAB -0.58%
IMCR -2.61%
IMGN 0.02%
IMGO 0.00%
IMMP 4.55%
IMMX -6.90%
IMNM -1.56%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX 0.00%
IMTX -1.58%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.72%
INAB 0.00%
INBX 0.46%
INCY -0.84%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM -2.20%
INMB 3.01%
INO -1.95%
INSM -0.81%
INTS -2.75%
INVA 0.25%
INZY 0.92%
IOBT -11.42%
IONS 0.34%
IOVA -2.37%
IPA 2.46%
IPHA 5.58%
IPSC -1.95%
IRON -2.54%
ISEE 0.38%
ITOS -1.50%
ITRM 1.67%
IVA 6.96%
IVVD -3.72%
JAGX 1.05%
JANX -4.02%
JAZZ -0.60%
JNCE 0.00%
JSPR -6.11%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.94%
KALV -1.95%
KDNY 0.22%
KMPH -0.34%
KNSA -2.84%
KNTE -0.38%
KOD -7.11%
KPRX 0.96%
KPTI -1.83%
KRBP -10.00%
KRON 1.05%
KROS -1.20%
KRRO -6.34%
KRTX 0.03%
KRYS -1.05%
KTRA 18.00%
KTTA 8.16%
KTTAW 0.92%
KURA -1.83%
KYMR -2.41%
KYTX -4.52%
KZIA 5.16%
KZR -1.49%
LABP 0.57%
LBPH -1.71%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.60%
LENZ -3.36%
LEXX 0.00%
LEXXW -14.63%
LGND -1.30%
LGNDV 0.00%
LGVN -9.61%
LIAN -8.28%
LIFE 2.70%
LIPO -7.10%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 0.52%
LPCN -4.05%
LPTX -1.10%
LQDA -0.24%
LRMR -1.92%
LSTA -4.06%
LTRN 1.76%
LUMO -1.32%
LVTX 0.00%
LXEO -4.33%
LXRX -2.06%
LYEL -35.05%
LYRA 2.33%
MACK 0.10%
MBIO -9.29%
MBRX -1.72%
MCRB 2.31%
MDGL -2.52%
MDNA -13.16%
MDWD 0.10%
MDXG -2.58%
MEIP -0.13%
MESO -1.78%
MGNX -3.03%
MGTA -7.74%
MGTX -2.97%
MGX -2.68%
MIRM -1.54%
MIRO 0.59%
MIST 1.54%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.63%
MLYS -5.79%
MNKD -1.14%
MNMD 0.14%
MNOV 2.11%
MNPR -5.01%
MOLN 0.28%
MOR 1.18%
MORF -3.77%
MREO -6.56%
MRKR 2.68%
MRNA -4.88%
MRNS -4.04%
MRSN -2.40%
MRTX -0.17%
MRUS 0.13%
MRVI -1.97%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.24%
MYMD 8.38%
NAMS 1.37%
NAMSW 0.43%
NAUT 1.15%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.09%
NERV -1.90%
NEXI 2.60%
NGM -1.28%
NGNE -2.03%
NKGN 5.88%
NKGNW 8.00%
NKTR -4.21%
NKTX -4.57%
NLSP -2.82%
NLSPW 26.67%
NMRA -0.91%
NMTR -42.97%
NOVN -24.84%
NRBO 10.16%
NRIX -0.34%
NRSN -7.05%
NRSNW 0.00%
NRXP -4.09%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -6.13%
NTRBW -31.07%
NUVL -2.00%
NVAX -2.28%
NVCT 3.59%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.40%
OABIW -10.06%
OBIO -2.49%
OBSV 0.00%
OCEA 0.00%
OCGN 4.24%
OCS -1.02%
OCUL -2.29%
OCUP 1.96%
ODT -4.27%
OKYO 1.51%
OLMA -5.54%
OMER -1.03%
OMGA 5.00%
ONCO 5.04%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY 0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 3.09%
ORGS -2.07%
ORIC -3.56%
ORMP 15.09%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.81%
OVID -1.44%
OYST 0.00%
PALI -0.87%
PASG -1.30%
PBLA -7.50%
PBM -7.99%
PBYI 1.69%
PCSA 0.00%
PCVX -0.43%
PDSB -2.53%
PEPG 0.27%
PGEN -3.03%
PHAR 1.51%
PHAS 0.00%
PHAT -1.07%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.22%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.10%
PLUR 6.01%
PMN 0.72%
PMVP -1.19%
PNT 0.16%
PPBT -4.26%
PRAX 0.63%
PRDS 0.93%
PRLD 0.00%
PROG -3.47%
PROK 0.00%
PRQR -0.01%
PRTA -2.65%
PRTC 0.49%
PRTG -0.50%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -5.11%
PSTX -0.97%
PTCT -0.28%
PTE -0.82%
PTGX -1.70%
PTIXW -49.04%
PULM 2.60%
PXMD 0.00%
PYPD 0.07%
PYXS 1.95%
QLGN -3.72%
QNCX 5.70%
QNRX 0.37%
QSI -11.97%
QSIAW -3.13%
QTTB -4.54%
QURE -0.22%
RAIN -1.63%
RANI 6.42%
RAPT -2.92%
RARE 1.10%
RCKT -7.81%
REGN -0.70%
RENB -3.41%
REPL -2.49%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 4.38%
RGLS -4.91%
RGNX -5.44%
RIGL -3.28%
RLAY -4.68%
RLMD 0.33%
RLYB -0.34%
RNA -0.42%
RNAC -5.65%
RNAZ -0.96%
RNXT 1.88%
ROIV -2.12%
ROIVW 4.56%
RPHM 0.00%
RPRX 0.00%
RPTX -2.93%
RUBY 2.70%
RVLP -32.05%
RVMD -1.13%
RVMDW -30.00%
RVNC 2.13%
RVPH -1.58%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.36%
RYTM -6.51%
RYZB 0.02%
RZLT 1.68%
SABS -1.37%
SABSW -11.81%
SAGE 1.56%
SANA -4.06%
SAVA -0.26%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH -0.51%
SCPS 0.00%
SEEL -4.48%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.03%
SGMT -1.69%
SGTX -2.56%
SIOX 22.63%
SLDB -7.05%
SLGL 4.00%
SLN -4.21%
SLNO -4.03%
SLRX 6.69%
SLS -2.58%
SMMT -2.75%
SNDX 0.84%
SNGX -4.52%
SNPX -0.81%
SONN -1.08%
SPPI -0.49%
SPRB 0.32%
SPRC -4.17%
SPRO 0.30%
SRNE -34.00%
SRPT -1.59%
SRRA 0.00%
SRRK -2.79%
SRZN -2.45%
STAB 0.00%
STOK -5.09%
STRO -2.84%
STSA 0.00%
STTK -4.78%
SURF -0.93%
SVRA -3.15%
SWTX 0.27%
SYBX -1.94%
SYRS -1.72%
TALS -0.73%
TARA -7.57%
TARS 0.06%
TBPH 0.60%
TCBP 2.73%
TCDA 0.00%
TCON -2.03%
TCRR 0.00%
TCRT 1.59%
TCRX 2.58%
TECH -0.15%
TENX -1.27%
TERN -7.72%
TFFP -3.05%
TGTX -2.97%
THRX 0.12%
TIL -0.20%
TLC 0.00%
TLSA -4.13%
TNGX -2.16%
TNXP -6.39%
TNYA -7.18%
TPST 2.87%
TRDA -3.86%
TRVI 1.15%
TRVN 2.92%
TSHA -24.24%
TSVT -3.19%
TTNP -9.27%
TVTX 0.63%
TYRA -7.09%
UBX -2.12%
UNCY -2.43%
URGN -1.15%
UTHR -0.32%
VACC 11.36%
VALN -2.89%
VAXX 106.32%
VBIV 0.78%
VBLT -8.77%
VCEL 0.09%
VCNX 10.35%
VCYT -1.23%
VERA -2.74%
VERU 0.78%
VERV -3.06%
VIGL 5.11%
VINC 1.62%
VIR 0.43%
VIRI -1.57%
VIRX 2.40%
VKTX -1.72%
VLON -13.04%
VNDA -2.28%
VOR -1.62%
VRCA -0.07%
VRDN -4.15%
VRNA -1.40%
VRPX 0.38%
VRTX 0.35%
VSTM -3.74%
VTGN -0.45%
VTVT -2.97%
VTYX -0.21%
VXRT -2.59%
VYGR -1.53%
VYNE -3.47%
VYNT 7.78%
WINT -3.24%
WVE -4.61%
XBIO 0.93%
XBIT 1.77%
XCUR 3.58%
XENE -2.81%
XERS 2.86%
XFOR 2.86%
XLO 2.00%
XLRN 0.00%
XNCR 0.47%
XOMA -3.57%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.92%
YMAB -1.80%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.51%
ZNTL -2.38%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-11-07 Omega Fund Vi, L.p. Buy 454 545 Common Stock
2023-11-07 Omega Fund Vi, L.p. Buy 287 213 Common Stock
2023-11-07 Omega Fund Vi, L.p. Buy 1 415 865 Common Stock
2023-11-07 Omega Fund Vi, L.p. Sell 2 615 533 Series B convertible preferred stock
2023-11-07 Omega Fund Vi, L.p. Sell 14 999 999 Series A convertible preferred stock
INSIDER POWER
-79.48
Last 16 transactions
Buy: 4 724 723 | Sell: 41 348 236
सहसंबंध (AI algo v.1.1b): Undervalued: 0.07% $16.16 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: 0.08 (neutral)
छोटा: 0.55 (weak)
Signal:(48.186) Neutral

Lexeo Therapeutics, Inc. सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Lexeo Therapeutics, Inc. सहसंबंध - मुद्रा/वस्त्र

The country flag 0.04
( neutral )
The country flag 0.50
( neutral )
The country flag 0.00
( neutral )
The country flag -0.09
( neutral )
The country flag 0.00
( neutral )
The country flag 0.25
( neutral )

Lexeo Therapeutics, Inc. वित्तीय

Annual 2022
राजस्व: $654 000
सकल लाभ: $654 000 (100.00 %)
EPS: $-2.40
FY 2022
राजस्व: $654 000
सकल लाभ: $654 000 (100.00 %)
EPS: $-2.40

Financial Reports:

No articles found.

Lexeo Therapeutics, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich\'s ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं

Total Execution Time: 1.5687730312347 seconds
Number of API calls: 3
Number of DB calls: 9